Middle East: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2022

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in the Middle East

In 2021, the Middle Eastern human and animal blood market decreased by -X% to $X, falling for the second year in a row after five years of growth. Over the period under review, consumption showed a remarkable increase. The level of consumption peaked at $X in 2019; however, from 2020 to 2021, consumption remained at a lower figure.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in the Middle East

In value terms, human and animal blood production declined slightly to $X in 2021 estimated in export price. Overall, production, however, posted a buoyant expansion. The pace of growth appeared the most rapid in 2016 with an increase of X%. Over the period under review, production attained the maximum level at $X in 2020, and then fell in the following year.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports in the Middle East

In 2021, overseas shipments of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses increased by X% to X tons for the first time since 2018, thus ending a two-year declining trend. In general, exports recorded a significant expansion. Over the period under review, the exports attained the peak figure at X tons in 2018; however, from 2019 to 2021, the exports remained at a lower figure.

In value terms, human and animal blood exports surged to $X in 2021. Over the period under review, exports posted prominent growth. Over the period under review, the exports attained the peak figure at $X in 2018; however, from 2019 to 2021, the exports stood at a somewhat lower figure.

Exports by Country

In 2021, Turkey (X tons) represented the major exporter of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, achieving X% of total exports. Jordan (X tons) held a X% share (based on physical terms) of total exports, which put it in second place, followed by Iran (X%). The United Arab Emirates (X tons) followed a long way behind the leaders.

From 2012 to 2021, the most notable rate of growth in terms of shipments, amongst the main exporting countries, was attained by Iran (with a CAGR of +X%), while the other leaders experienced more modest paces of growth.

In value terms, the largest human and animal blood supplying countries in the Middle East were Turkey ($X), Jordan ($X) and the United Arab Emirates ($X), together accounting for X% of total exports. Iran lagged somewhat behind, accounting for a further X terms of the main exporting countries, Iran, with a CAGR of +X%, saw the highest growth rate of the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The export price in the Middle East stood at $X per ton in 2021, reducing by -X% against the previous year. Over the period under review, the export price saw a abrupt shrinkage. The most prominent rate of growth was recorded in 2017 when the export price increased by X% against the previous year. The level of export peaked at $X per ton in 2018; however, from 2019 to 2021, the export prices failed to regain momentum.

Prices varied noticeably by the country of origin: the country with the highest price was the United Arab Emirates ($X per ton), while Iran ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by the United Arab Emirates (+X%), while the other leaders experienced mixed trends in the export price figures.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports in the Middle East

In 2021, the amount of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses imported in the Middle East surged to X tons, growing by X% on 2020. Over the period under review, imports recorded a remarkable increase. The pace of growth was the most pronounced in 2017 when imports increased by X%. The volume of import peaked at X tons in 2019; however, from 2020 to 2021, imports remained at a lower figure.

In value terms, human and animal blood imports skyrocketed to $X in 2021. Overall, imports saw prominent growth. The most prominent rate of growth was recorded in 2017 when imports increased by X% against the previous year. The level of import peaked at $X in 2019; however, from 2020 to 2021, imports stood at a somewhat lower figure.

Imports by Country

In 2021, Saudi Arabia (X tons) was the major importer of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, creating X% of total imports. It was distantly followed by Turkey (X tons), the United Arab Emirates (X tons) and Israel (X tons), together comprising a X% share of total imports. Iran (X tons), Iraq (X tons) and Kuwait (X tons) took a little share of total imports.

Saudi Arabia was also the fastest-growing in terms of the human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses imports, with a CAGR of +X% from 2012 to 2021. At the same time, the United Arab Emirates (+X%), Turkey (+X%), Kuwait (+X%), Israel (+X%), Iran (+X%) and Iraq (+X%) displayed positive paces of growth. While the share of Saudi Arabia (+X p.p.) increased significantly in terms of the total imports from 2012-2021, the share of Israel (-X p.p.), Iran (-X p.p.) and Iraq (-X p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Saudi Arabia ($X) constitutes the largest market for imported human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in the Middle East, comprising X% of total imports. The second position in the ranking was taken by Turkey ($X), with a X% share of total imports. It was followed by Israel, with a X% share.

From 2012 to 2021, the average annual growth rate of value in Saudi Arabia amounted to +X%. The remaining importing countries recorded the following average annual rates of imports growth: Turkey (+X% per year) and Israel (+X% per year).

Import Prices by Country

In 2021, the import price in the Middle East amounted to $X per ton, declining by -X% against the previous year. Overall, the import price recorded a slight setback. The pace of growth was the most pronounced in 2020 when the import price increased by X%. As a result, import price attained the peak level of $X per ton, and then shrank rapidly in the following year.

Prices varied noticeably by the country of destination: the country with the highest price was Kuwait ($X per ton), while Iraq ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Israel (+X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :